For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Genetics Institute, Inc.

USPTO Granted Patents = 389

CIPO Patents = 22

EPO Patents = 15

Trademarks = 3

Forward Citations = 12,930

Loading Chart...

Loading Chart...

322 inventors (with patents filed for the assignee):

John Martin Wozney (46 out of 62 patents)

Kenneth A Jacobs (43 out of 47 patents)

Edward R LaVallie (34 out of 42 patents)

4. Anthony J Celeste (33 out of 36 patents)

5. John M McCoy (31 out of 60 patents)

6. Vicki A Rosen (30 out of 35 patents)

7. Lisa A Racie (29 out of 32 patents)

8. David Merberg (24 out of 25 patents)

9. Elizabeth A Wang (24 out of 31 patents)

10. Vikki A Spaulding (23 out of 28 patents)

11. Mary Collins (23 out of 35 patents)

12. Steven C Clark (22 out of 33 patents)

13. Maurice Treacy (22 out of 23 patents)

14. Gary S Gray (20 out of 33 patents)

15. Neil M Wolfman (16 out of 39 patents)

Core Competencies:

P-Selectin Ligand Protein

Human GIL-19 Proteins

IL-12 Antagonists

Cytokine Receptor Family

Anti-GL50 Antibodies

Recombinant Bone Morphogenetic Proteins

Monoclonal Antibodies

T Cell Proliferation Inhibition

Hyaluronic Acid Derivatives

Interleukin-22

Factor VIII Proteins

Autoimmune Disease Treatments

389 patents: Sort by Forward Citations

1. 8232252 - P-selectin ligand protein (2012-07-31),

2. 8048984 - Human GIL-19/AE289 proteins (2011-11-01),

3. 8012475 - Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases (2011-09-06),

4. 7994292 - MU-1, member of the cytokine receptor family (2011-08-09),

5. 7976840 - Use of anti-GL50 antibodies for the downmodulation of an immune response (2011-07-12),

6. 7927835 - Nucleic acids encoding P-selectin ligand fusion proteins (2011-04-19),

7. 7842669 - Methods and compositions for healing and repair of articular cartilage (2010-11-30),

8. 7820796 - Methods for producing Factor VIII proteins (2010-10-26),

9. 7709214 - Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1 (2010-05-04),

10. 7705123 - MU-1, member of the cytokine receptor family (2010-04-27),

11. 7678885 - Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (2010-03-16),

12. 7674591 - Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding (2010-03-09),

13. 7666421 - Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2 (2010-02-23),

14. 7638604 - Monoclonal antibodies against interleukin-22 (2009-12-29),

15. 7638492 - Methods of upmodulating an immune response with non-activating forms of B7-4 (2009-12-29),

Genetics Institute, Inc. is a biotechnology company focused on developing innovative genetic therapies and solutions to improve the lives of patients. With a team of expert scientists and researchers, we work tirelessly to discover and advance breakthrough treatments for genetic diseases and disorders. Visit our website to learn more about our cutting-edge research, clinical trials, and commitment to transforming the future of healthcare through genetics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

389 Patents

#10 in Cambridge, MA

#70 in Massachusetts

#1,155 in US

#2,313 in the World

Cambridge, MA, United States of America

Genetics Institute, Inc.

Forward Citations = 12,930

322 inventors:

John Martin Wozney (46 out of 62 patents)

Kenneth A Jacobs (43 out of 47 patents)

Edward R LaVallie (34 out of 42 patents)

4. Anthony J Celeste (33 out of 36 patents)

5. John M McCoy (31 out of 60 patents)

Please report any incorrect information to support@idiyas.com

Loading…